FW
FEBBO WILLIAM J Chief Executive Officer
C-suite M
US US · SEC (Form 4)
€55,623
▲ Purchases (1 ops.)
Discover the full record of transactions filed by FEBBO WILLIAM J, Chief Executive Officer. Insider active across 3 companies, notably OptimizeRx Corp. Aggregated, 27 reports have been published. Total volume traded: €11.1m. The latest transaction was filed on 27 May 2022 — Acquisition. Regulator: SEC (Form 4). All data is free.
Declarations 27 total
€55,623 30,000 shares @ €1.8541 100.0% of flow
Common Stock
SEC:0001213900-22-030199:0 · 27 May 2022
Ideal exit: 21 Feb 2023 (T+270) 5,981 shares
Common Stock
SEC:0001019056-22-000310:0 · 31 Mar 2022
€72,352 20,000 shares @ €3.6176 0.40% mcap 100.0% of flow
Common Stock
SEC:0001019056-22-000256:0 · 3 Mar 2022
€351,109 9,200 shares @ €38.164 0.36% mcap 3.2% of flow
Common Stock
SEC:0001213900-22-008987:0 · 18 Feb 2022
45,586 shares
Common Stock
SEC:0001019056-22-000226:0 · 14 Feb 2022
€334,679 8,140 shares @ €41.1154 0.34% mcap 6.3% of flow
Common Stock
SEC:0001213900-22-002854 · 18 Jan 2022
€334,679 8,140 shares @ €41.1154 0.34% mcap 3.0% of flow
Common Stock
SEC:0001213900-22-002854:0 · 18 Jan 2022
9,627 shares
Common Stock
SEC:0001213900-22-001562:0 · 7 Jan 2022
9,627 shares
Common Stock
SEC:0001213900-22-001562 · 7 Jan 2022
3,329 shares
Common Stock
SEC:0001019056-22-000016 · 31 Dec 2021
3,329 shares
Common Stock
SEC:0001019056-22-000016:0 · 31 Dec 2021
€807,308 16,666 shares @ €48.4404 0.83% mcap 15.1% of flow
Common Stock (pursuant to 10B5-1 plan)
SEC:0001213900-21-066031 · 15 Dec 2021
€807,308 16,666 shares @ €48.4404 0.83% mcap 7.3% of flow
Common Stock (pursuant to 10B5-1 plan)
SEC:0001213900-21-066031:0 · 15 Dec 2021
€1m 16,666 shares @ €71.8253 1.22% mcap 22.5% of flow
Common Stock (pursuant to 10B5-1 plan)
SEC:0001213900-21-060341 · 15 Nov 2021
€1m 16,666 shares @ €71.8253 1.22% mcap 10.9% of flow
Common Stock (pursuant to 10B5-1 plan)
SEC:0001213900-21-060341:0 · 15 Nov 2021
€1m 16,666 shares @ €72.6393 1.24% mcap 22.7% of flow
Common Stock (pursuant to 10B5-1 plan)
SEC:0001213900-21-053524 · 15 Oct 2021
€1m 16,666 shares @ €72.6393 1.24% mcap 11.0% of flow
Common Stock (pursuant to 10B5-1 plan)
SEC:0001213900-21-053524:0 · 15 Oct 2021
8,389 shares
Common Stock
SEC:0001019056-21-000519 · 30 Sept 2021
8,389 shares
Common Stock
SEC:0001019056-21-000519:0 · 30 Sept 2021
€926,923 16,666 shares @ €55.6176 0.95% mcap 17.4% of flow
Common Stock (pursuant to 10B5-1 plan)
SEC:0001213900-21-048613 · 15 Sept 2021
€926,923 16,666 shares @ €55.6176 0.95% mcap 8.4% of flow
Common Stock (pursuant to 10B5-1 plan)
SEC:0001213900-21-048613:0 · 15 Sept 2021
8,600 shares
Common Stock
SEC:0001213900-21-048251 · 13 Sept 2021
8,600 shares
Common Stock
SEC:0001213900-21-048251:0 · 13 Sept 2021
€855,374 16,666 shares @ €51.3245 0.87% mcap 16.0% of flow
Common Stock (pursuant to 10B5-1 plan)
SEC:0001213900-21-043480 · 16 Aug 2021
€855,374 16,666 shares @ €51.3245 0.87% mcap 7.8% of flow
Common Stock (pursuant to 10B5-1 plan)
SEC:0001213900-21-043480:0 · 16 Aug 2021
25 of 27 declarations
Load more (2 remaining) About FEBBO WILLIAM J William J. Febbo is an executive at Modular Medical, Inc.